Unmasking P-values
20 May 2020
Take Home Messages:
- P-values say nothing about effect size, look up the confidence interval and point estimate to address clinical relevance of any “findings”
- The P-value does not measure the likeliness of H0 being true
- Rejection of the null hypothesis does not mean that the true effect is as specified in the alternative hypothesis that the study was powered for
- H0 cannot be proven. A non-significant P-value does not prove that the null hypothesis is true
- P-values are influenced by sample size (power).
- There is always a chance that a statistically significant finding be a false positive
- The chance of false positive findings increases sharply with the number of tests
References
Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature 567, 305-307 (2019).doi: 10.1038/d41586-019-00857-9
Cristea IA, Ioannidis JPA. P values in display items are ubiquitous and almost invariably significant: A survey of top science journals. PLoS One. 2018;13(5):e0197440. Published 2018 May 15. doi:10.1371/journal.pone.0197440
Fisher RA. Statistical Methods for Research Workers. Edinburgh, UK: Oliver and Boyd; 1925.
Greenland S, Senn SJ, Rothman KJ, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31:337–350.
Goodman S. A dirty dozen: twelve p-value misconceptions Semin Hematol. 2008 Jul;45(3):135-40. doi: 10.1053/j.seminhematol.2008.04.003
Ioannidis JPA. The Proposal to Lower P Value Thresholds to .005. JAMA. 2018;319(14):1429‐1430. doi:10.1001/jama.2018.1536
Ioannidis JPA. Publishing research with P-values: Prescribe more stringent statistical significance or proscribe statistical significance?. Eur Heart J. 2019;40(31):2553‐2554. doi:10.1093/eurheartj/ehz555
Neyman J, Pearson E. On the problem of the most efficient tests of statistical hypotheses. Philos Trans R Soc Lond A. 933;231:289–337.
Schroeber P, Bossers SM, Schwarte LA. Statistical Significance Versus Clinical Importance of Observed Effect Sizes: What Do P Values and Confidence Intervals Really Represent?. Anesth Analg. 2018;126(3):1068‐1072. doi:10.1213/ANE.0000000000002798
Szucs D, Ioannidis JPA. When null hypothesis significance testing is unsuitable for research: a reassessment. Front Hum Neurosci.2017;11:390.
Wasserstein RL, Schirm AL and Lazar NA (2019) Moving to a World Beyond “p < 0.05”, The American Statistician, 73:sup1, 1-19, DOI: 10.1080/00031305.2019.1583913
Related News
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
Professor Benjamin Besse becomes President of EORTC
26 Jun 2026
CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer
24 Jun 2026
EORTC welcomes EU Biotech Act and calls for refinements to enable patient-centred trials
24 Jun 2026
New study confirms a key quality of life tool can be used with adolescents with cancer
9 Jun 2026
“Changing practice, improving lives”: EORTC publishes its Annual Report 2025
8 Jun 2026
This Clinical Trials Day, EORTC announces the upcoming Summit for Clinical Cancer Research
20 May 2026
